Amicus Therapeutics (0HF9.L) Stock Price
$7.98 0.9%
to add to portfolio
AI Score
-
Alternative
7 -
Fundamental
2 -
Technical
7
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals. Scores are designed to reflect relative strength or weakness across these factors, helping users compare companies and track changes over time.
Sign up to get access to more historical data and insights on Amicus Therapeutics, AI stock picks, stock alerts and much more.
0HF9.L AI Stock Analysis
AI stock analysis for 0HF9.L is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Amicus Therapeutics (0HF9.L) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Amicus Therapeutics (0HF9.L) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Amicus Therapeutics (0HF9.L), currently trading at $7.98, will... Sign up to access price prediction.
About 0HF9.L
-
Amicus Therapeutics, Inc.
-
Symbol
0HF9.L
-
Market
LSE
-
Industry
Medical - Pharmaceuticals
-
Market Cap
2.3B
Similar Stocks
 |
Vertex Pharmaceuticals Incorporated 0QZU.L |
$394.5 0.3% |
7 |
 |
Neurocrine Biosciences 0K6R.L |
$142.1 0.9% |
7 |
 |
Emergent BioSolutions Inc. 0IGA.L |
$8.23 1.5% |
5 |
 |
Abeona Therapeutics Inc. 0H7R.L |
$6.64 2.1% |
5 |
 |
Esperion Therapeutics 0IIM.L |
$2.8 2.9% |
6 |
News
0HF9.L Alternative Data
Web Traffic
Amicus Therapeutics receives an estimated 18145 monthly visitors to amicusrx.com, which is down by -0.1% over the last month.
-
Web Traffic
18145
-
Change from Previous Month
0.1%
-
3 Month Change
18.9%
-
YoY Change
18.9%
Twitter Followers
Amicus Therapeutics has 2,165 Twitter Followers on its main Twitter (also known as X) account, which is up by 0% over the last month.
-
Twitter Followers
2165
-
Daily Change
0.1%
-
1 Month Change
0%
-
3 Month Change
0.8%
-
YoY Change
0.8%
Facebook Engagement
Amicus Therapeutics has engaged 3 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
3
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Amicus Therapeutics has 107 subscribers on its main Youtube channel, up by 0.9% over the last month.
-
Youtube Subscribers
107
-
Daily Change
0%
-
1 Month Change
0.9%
-
3 Month Change
1.9%
-
YoY Change
1.9%
Job Postings
Amicus Therapeutics has an estimated 17 open job postings, which is down -5.6% over the last month.
-
Job Postings
17
-
Daily Change
6.3%
-
1 Month Change
5.6%
-
3 Month Change
21.4%
-
YoY Change
21.4%
Reddit Mentions
Amicus Therapeutics has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
50,248 are following Amicus Therapeutics on LinkedIn, up by 2.2% over the last month.
-
LinkedIn Followers
50248
-
Daily Change
2.2%
-
1 Month Change
2.2%
-
3 Month Change
6.9%
-
YoY Change
6.9%
Business Outlook
According to employee reviews, the business outlook among employees at Amicus Therapeutics is 74 out of 100 (bullish).
-
Business Outlook
74
-
Change from Previous Month
0%
-
3 Month Change
0%
-
YoY Change
0%
LinkedIn Employees
According to LinkedIn, Amicus Therapeutics has 616 employees.
-
LinkedIn Employees
616
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0.7%
-
YoY Change
0.7%
News Mentions
Amicus Therapeutics was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
50%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
0HF9.L Financials
0HF9.L Key Metrics
-
Total Revenue
$125.2M
-
Net Income
-$21.7M
-
Earnings per Share
-$0.07
-
Free cash flow
$7.5M
-
EBITDA
-$4.8M
-
EBITDA Ratio
-0.0379484
-
Total Assets
$789.8M
0HF9.L 2-year Revenue & Income
0HF9.L 2-year Free Cash Flow
0HF9.L Technicals
0HF9.L SMA
0HF9.L RSI
FAQ
What's the current price of Amicus Therapeutics (0HF9.L) Stock?
The price of an Amicus Therapeutics (0HF9.L) share is $7.98.
What's the market cap of Amicus Therapeutics?
The current market cap of Amicus Therapeutics is 2.3B.
What are some stocks similar to Amicus Therapeutics (0HF9.L) that investors often compare it to?
Amicus Therapeutics (0HF9.L) is often compared to similar stocks such as Vertex Pharmaceuticals Incorporated, Neurocrine Biosciences, Emergent BioSolutions Inc., Abeona Therapeutics Inc. and Esperion Therapeutics.
What is the forecast for Amicus Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Amicus Therapeutics' stock price to be around $8.24 in 2026. Starting from the current price of $7.98, this represents a 3.2% change in price, indicating a neutral outlook for the stock.
How to buy Amicus Therapeutics (0HF9.L) Stock?
Amicus Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Amicus Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.